"cell carcinoma" trang 6 - tải miễn phí từ tailieunhanh
ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma

ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma
9    50    1
Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study
9    45    1
Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes

Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes
14    30    1
The PRO-RCC study: A long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs

The PRO-RCC study: A long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs
8    1    1
An integrated model for prognosis in vulvar squamous cell carcinoma

An integrated model for prognosis in vulvar squamous cell carcinoma
10    8    1
Micronodular basal cell carcinoma of the scrotum: A case report and review of the literature

Micronodular basal cell carcinoma of the scrotum: A case report and review of the literature
5    15    1
Atezolizumab plus modified docetaxelcisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: A randomized, non-comparative phase II SCARCE GERCOR trial

Atezolizumab plus modified docetaxelcisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: A randomized, non-comparative phase II SCARCE GERCOR trial
11    89    0
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma

Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
14    71    0
Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery

Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery
11    96    0
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
8    34    1
Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: An NCDB analysis

Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: An NCDB analysis
9    26    1
Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques

Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques
10    58    1
Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: A single-institution experience

Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: A single-institution experience
11    30    1
Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report

Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report
5    72    1
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
14    69    1
Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)

Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)
11    43    1
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma
12    34    1
Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays
7    71    1
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma

Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
7    47    1
Clinical characteristics and prognosis of ovarian clear cell carcinoma: A 10-year retrospective study

Clinical characteristics and prognosis of ovarian clear cell carcinoma: A 10-year retrospective study
15    42    1